Presley Gerber, the son of model Cindy Crawford and businessman Rande Gerber, passed away at age 27 at a rehabilitation facility in California. This tragic event has brought renewed attention to the dangers associated with overdose, withdrawal, and addiction recovery challenges.
Details Surrounding Gerber’s Passing
The Los Angeles County Medical Examiner’s Office confirmed Presley’s death, although the official cause has yet to be determined. Audio recordings obtained by People magazine suggest that emergency responders were called to a facility on Berkeley Street for a reported cardiac arrest. Another dispatch indicated a potential overdose. An autopsy has been completed, but the cause of death depends on further testing.
Presley’s Public Struggles
Presley had been open about his struggles with substance use and mental health issues. His family, through a representative, has requested privacy during this difficult time.
Risks in Recovery
Dr. Nicholas Kardaris, CEO and chief clinical officer of the New York Center for Living, discussed the potential hidden risks during recovery. Although he has not treated Presley and is not linked to the case, he emphasized that recovery is a complex journey.
“People are in rehab because they’re struggling with addiction. It doesn’t mean they’re cured of their addiction,” Kardaris explained.
Treatment facilities strive to create a safe environment, but not all dangers related to addiction can be eliminated. Challenges like withdrawal symptoms and medication-related complications may arise.
Withdrawal Concerns
Withdrawal symptoms can range from uncomfortable to life-threatening depending on the substance and the individual’s dependency level. Benzodiazepines, alcohol, and opioid withdrawals are particularly risky.
Kardaris noted, “Benzodiazepine withdrawal can trigger seizures, delirium and other life-threatening complications.”
Withdrawal from opioids, while extremely uncomfortable, is generally not fatal. The greater risk comes post-detox when tolerance levels decrease, leading to potential overdose if previous usage levels are resumed.
Ibogaine Treatment Insights
Presley had previously mentioned undergoing an ibogaine treatment in Mexico. Kardaris cautioned against drawing conclusions from this treatment, noting that ibogaine is not FDA-approved in the U.S. and remains largely unregulated.
“Ketamine, ayahuasca, and ibogaine are treatments that have gained public interest,” he said. “There is some research indicating potential benefits, but regulation is limited.”
Choosing a Treatment Program
Kardaris advised families to thoroughly vet treatment centers, ensuring they are licensed and have qualified professionals. Proper protocols for managing withdrawal, medication, and emergencies are crucial.
“Families should make sure licensed professionals are working there and that the program has a strong reputation,” Kardaris emphasized.
This tragic event underscores the importance of understanding the complexities involved in addiction recovery and the constant vigilance needed during and after treatment.
Leave a Reply